newsfilter
← Latest News
PR Newswire·

BiondVax to host a Hebrew-language analyst and investor webinar on April 6th

JERUSALEM, April 5, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and oth